In this episode of Expert Answers join Dr. Matt Kaeberlein, a Professor at the University of Washington School of Medicine, as he answers questions from a recent webinar that focuses on translational geroscience, the drug rapamycin to target biological aging, and the Dog Aging Project.

For more information, to watch the webinar, or to download a copy of the full Q&A Report, click here.